Adverse outcomes and predictors of underuse of antithrombotic therapy in medicare beneficiaries with chronic atrial fibrillation

Keyphrases

• Advanced Age 16%
• Adverse Outcomes 100%
• Am(III) 16%
• Anticoagulation 16%
• Antiplatelet Therapy 16%
• Antithrombotic Therapy 100%
• Aspirin 66%
• Aspirin Therapy 16%
• Chart Review 33%
• Chronic Atrial Fibrillation 100%
• Comorbid Conditions 16%
• Demographic Factors 16%
• Elderly Frail 16%
• Female Gender 16%
• Frail Elderly 16%
• Frail Population 16%
• Hospital Discharge 33%
• Hospital Discharge Outcome 16%
• Hospitalization 16%
• Ischemic Events 16%
• Medicare Beneficiaries 100%
• Medicare Claims 16%
• Medicare Claims Data 16%
• Missouri 33%
• Myocardial Infarction 16%
• Non-valvular Atrial Fibrillation 50%
• Patient Selection 16%
• Randomized Controlled Trial 16%
• Relative Contraindications 16%
• Relative Risk Reduction 33%
• Risk Factors 16%
• Rural Residency 16%
• Stroke Ischemic 16%
• Stroke Risk Factors 16%
• Transient Ischemic Attack 33%
• Underuse 100%
• Warfarin 83%
• Warfarin Therapy 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Acetylsalicylic Acid 71%
• Adverse Outcome 100%
• Antiplatelet 14%
• Antithrombotic Therapy 100%
• Atrial Fibrillation 42%
• Cerebrovascular Accident 42%
• Chronic Atrial Fibrillation 100%
• Heart Infarction 14%
• Randomized Controlled Trial 14%
• Transient Ischemic Attack 28%
• Warfarin 100%